PI THERAPEUTICS
Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and has operated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
PI THERAPEUTICS
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.pi-tx.com
Total Employee:
1+
Status:
Active
Total Funding:
19.7 M USD
Technology used in webpage:
DNS.COM
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
LogicBio Therapeutics
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Founder
Investors List
CBG Asset Management
CBG Asset Management investment in Series B - Pi Therapeutics
RMGP Biopharma Investment Fund
RMGP Biopharma Investment Fund investment in Series B - Pi Therapeutics
Quark Venture
Quark Venture investment in Series B - Pi Therapeutics
Arkin Bio Ventures
Arkin Bio Ventures investment in Series B - Pi Therapeutics
Pontifax
Pontifax investment in Series B - Pi Therapeutics
GF Securities
GF Securities investment in Series B - Pi Therapeutics
